000			01656nam a2200133Ia 4500
008			220620s9999||||xx |||||||||||||| ||und||
020			_a9783040000000
245		0	_aBioactive Molecules from Extreme Environments II
546			_aEnglish[eng]
650			_aArctic/Antarctic||marine bioprospecting||marine natural product||terpene||terpenoid||biotechnological application||drug discovery||microalgae||Muriellopsis||spray drying||freeze-drying||lutein||supercritical fluid extraction||cyclic tripeptides||antibacterial||Antarctica sponge-derived fungus||Aspergillus insulicola||psychrophiles||Antarctic bacteria||Lipopolysaccharide (LPS)||lipid A||structural characterization||MALDI-TOF mass spectrometry||marine natural products||Mollusca||Gastropoda||chemical ecology||crustin||antimicrobial peptides||shrimp||deep-sea hydrothermal vent||deep-sea microorganism||fungus||Penicillium griseofulvum||anti-food allergy||fungal metabolites||Paenibacillus||Arctic||Svalbard||Marfey’s method||DP4 calculation||quinone reductase||lipopeptide||3-amino-2-pyrrolidinone||green synthesis||biomaterials||metal||antibiotics||nanotechnology||deep sea natural products||Mariana Trench||Dermacoccus abyssi MT 1.1T||13C-NMR chemical shift linear and multiple regression||(DFT)-UV-Vis spectral calculation||phenoxazine||dermacozine||absorption maxima in the near infrared region||Antarctica||sponges||mycalols||marine biotechnology||antifungal activity||Bacillus amyloliquefaciens||Panama disease||Fusarium oxysporum f. sp. cubense||bioactive compound||iturin A5||n/a
700			_aGiordano, Daniela
856			_uhttps://mdpi.com/books/pdfview/book/4754
942			_cEB
999			_c27422 _d27422